海西新药（02637）今日在港交所正式挂牌上市，盘中大涨21.53%，引发市场热烈关注。
据悉，海西新药此次全球发售1150万股H股，最终发售价定为每股86.40港元，位于招股价区间的上限。公司香港公开发售部分获得3165.1倍超额认购，认购热情异常高涨。国际配售部分也获得6.3倍认购。公司通过此次发行共筹集净额约9.4亿港元。
海西新药是一家专注于仿制药研发和生产的制药公司，产品涵盖消化系统、心血管系统等多个治疗领域。公司2024年实现营收4.67亿元，净利润1.36亿元，显示出强劲的业绩增长。其核心产品安必力和海慧通在各自领域均占据重要市场份额，为公司贡献了大部分收入。投资者对公司的增长潜力和市场地位表现出强烈信心，推动股价在首日交易中大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.